Market Research Logo

European Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2016 - MedView

European Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2016 - MedView

The European diabetes diagnosis, treatment and drug delivery market increased in 2015 and growth is expected to persist over the forecast period. Market growth will be driven by the growing prevalence of diabetes in Europe and technological advancements made in certain segments, particularly insulin pumps and continuous glucose monitoring (CGM). Limitations to market growth include pricing pressure due to increased competition in the test strip and pen needle segments, as well as budgetary pressure to decrease diabetes expenditure of national healthcare organizations.

Diabetes mellitus is a multifaceted disease that yields various approaches in terms of diagnosis, treatment and drug delivery. Products for maintenance and treatment of diabetes can be of high volume and low cost or of relatively low volume and high cost.


EXECUTIVE SUMMARY
EUROPEAN MARKET FOR DIABETES MONITORING, TREATMENT AND DRUG DELIVERY
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 INTRODUCTION
2.1.1 Types of Diabetes
2.1.2 Diabetes Complications
2.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes
2.1.4 Signs and Symptoms
2.1.5 Diabetes Monitoring
2.1.6 Treatment
2.1.7 Drug Delivery Systems
EUROPEAN DIABETES MONITORING, TREATMENT AND DRUG DELIVERY MARKET OVERVIEW
3.1 MARKET OVERVIEW
3.2 TREND ANALYSIS
3.3 CURRENCY EXCHANGE RATE
3.4 DRIVERS AND LIMITERS
3.4.1 Market Drivers
3.4.2 Market Limiters
3.5 COMPETITIVE MARKET SHARE ANALYSIS
3.6 MERGERS AND ACQUISITIONS
COUNTRY PROFILES
4.1 INTRODUCTION
4.1.1.1 Population
4.1.1.2 GDP Per Capita
4.1.1.3 Units
4.2 GERMANY
4.3 FRANCE
4.4 UNITED KINGDOM
4.5 ITALY
4.6 SPAIN
4.7 BENELUX
4.8 SCANDINAVIA
4.9 AUSTRIA
4.10 SWITZERLAND
4.11 PORTUGAL
ABBREVIATIONS
List of Charts
Chart 1 1: Diabetes Diagnosis, Treatment and Drug Delivery, Europe, 2012 – 2022
Chart 1 2: Diabetes Diagnosis, Treatment and Drug Delivery Market Overview, Europe, 2012 & 2022
Chart 3 1: Total Diabetes Diagnosis, Treatment and Drug Delivery Market by Segment, Europe, 2012 – 2022 (€M)
Chart 3 2: Total Diabetes Diagnosis, Treatment and Drug Delivery Market Breakdown, Europe, 2015
Chart 3 3: Total Diabetes Diagnosis, Treatment and Drug Delivery Market Breakdown, Europe, 2022
Chart 3 4: Growth Rates by Segment, Total Diabetes Diagnosis, Treatment and Drug Delivery Market, Europe, 2012 – 2022
Chart 3 5: Leading Competitors, Diabetes Diagnosis, Treatment and Drug Delivery Market, Europe, 2015
Chart 4 1: Country Profile, Germany, 2015
Chart 4 2: Country Profile, France, 2015
Chart 4 3: Country Profile, United Kingdom, 2015
Chart 4 4: Country Profile, Italy, 2015
Chart 4 5: Country Profile, Spain, 2015
Chart 4 6: Country Profile, Benelux, 2015
Chart 4 7: Country Profile, Scandinavia, 2015
Chart 4 8: Country Profile, Austria, 2015
Chart 4 9: Country Profile, Switzerland, 2015
Chart 4 10: Country Profile, Portugal, 2015
List of Figures
Figure 1 1: Diabetes Diagnosis, Treatment and Drug Delivery Competitor Market Share Ranking by Segment, Europe, 2015 (1 of 2)
Figure 1 2: Diabetes Diagnosis, Treatment and Drug Delivery Competitor Market Share Ranking by Segment, Europe, 2015 (2 of 2)
Figure 1 3: Companies Researched in this Report, Europe, 2015
Figure 1 4: Factors Impacting the Diabetes Diagnosis, Treatment and Drug Delivery Market by Segment, Europe (1 of 2)
Figure 1 5: Factors Impacting the Diabetes Diagnosis, Treatment and Drug Delivery Market by Segment, Europe (2 of 2)
Figure 1 6: Recent Events in the Diabetes Diagnosis, Treatment and Drug Delivery Market, Europe, 2012 – 2016
Figure 2 1: Major Types of Diabetes and Related Pathologies, Europe, 2015
Figure 2 2: Risk Factors Associated with Type 1 and Type 2 Diabetes, Europe, 2015
Figure 2 3: Signs and Symptoms Associated with Type 1 and Type 2 Diabetes, Europe, 2015
Figure 3 1: Total Diabetes Diagnosis, Treatment and Drug Delivery Market by Segment, Europe, 2012 – 2022 (€M) (1 of 2)
Figure 3 2: Total Diabetes Diagnosis, Treatment and Drug Delivery Market by Segment, Europe, 2012 – 2022 (€M) (2 of 2)
Figure 3 3: Total Diabetes Diagnosis, Treatment and Drug Delivery Market by Segment, Europe, 2012 – 2022 (US$M) (1 of 2)
Figure 3 4: Total Diabetes Diagnosis, Treatment and Drug Delivery Market by Segment, Europe, 2012 – 2022 (US$M) (2 of 2)
Figure 3 5: Growth Rates by Segment, Total Diabetes Diagnosis, Treatment and Drug Delivery Market, Europe, 2012 – 2022 (1 of 2)
Figure 3 6: Growth Rates by Segment, Total Diabetes Diagnosis, Treatment and Drug Delivery Market, Europe, 2012 – 2022 (2 of 2)
Figure 3 7: Currency Exchange Rate, 2015
Figure 3 8: Drivers and Limiters, Diabetes Diagnosis, Treatment and Drug Delivery Market, Europe, 2015
Figure 3 9: Leading Competitors, Diabetes Diagnosis, Treatment and Drug Delivery Market, Europe, 2015 (1 of 2)
Figure 3 10: Leading Competitors, Diabetes Diagnosis, Treatment and Drug Delivery Market, Europe, 2015 (2 of 2)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report